Obesity-related hypogonadotropic hypogonadism is a well-characterized condition in men
(termed male obesity-related secondary hypogonadism; MOSH); however, an equivalent …

Inositols are insulin-sensitizing compounds of promising efficacy in the management of
polycystic ovary syndrome (PCOS). On the one hand, myo-inositol (myo-ins) plays a …

Polycystic ovary syndrome (PCOS) is a common endocrinopathy occurring in reproductive-
age women. Hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic …

Context Polycystic ovary syndrome (PCOS) affects more than 1 in 10 women. Objective As
part of the 2023 International PCOS Guidelines update, comparisons between combined …

Kisspeptin (KP) and neurokinin B (NKB) are neuropeptides that govern the reproductive
endocrine axis through regulating hypothalamic gonadotropin-releasing hormone (GnRH) …

Psychotropic drug–related weight gain (PDWG) is a common occurrence and is highly
associated with non-initiation, discontinuation, and dissatisfaction with psychiatric drugs …

Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder
affecting females across the lifespan. Eating disorders (EDs) are psychiatric conditions that …

Polycystic ovary syndrome (PCOS), characterized by abnormal menstrual periods, elevated
androgen levels and polycystic ovary morphology on ultrasound, is the most common …

Purpose The purpose of this review is to examine the current evidence on the potential role
of Mediterranean diet (MD) in the prevention and management of endocrine disorders and …

Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In
2018, the first evidence‐based guideline on assessment and management of PCOS was …